Search

Search Constraints

You searched for: Author/Creator Keime-Guibert, Florence

Search Results

1. Calculating the net clinical benefit in neuro-oncology clinical trials using two methods: quality-adjusted survival effect sizes and joint modeling. Issue 1 (29th October 2020)

2. Factors associated with health-related quality of life (HRQoL) deterioration in glioma patients during the progression-free survival period. Issue 12 (11th April 2022)

3. Measuring change in health-related quality of life: the impact of different analytical methods on the interpretation of treatment effects in glioma patients. Issue 6 (7th June 2020)

4. Model-based computational precision medicine to develop combination therapies for autoimmune diseases. (2nd January 2022)

5. QOLP-03. MEASURING CHANGE IN HEALTH-RELATED QUALITY OF LIFE: THE ADDED VALUE OF ANALYSIS ON THE INDIVIDUAL PATIENT LEVEL IN GLIOMA PATIENTS IN CLINICAL DECISION MAKING. (11th November 2019)

6. QOLP-04. CALCULATING THE NET CLINICAL BENEFIT IN BRAIN TUMOR TRIALS BY COMBINING SURVIVAL AND HEALTH-RELATED QUALITY OF LIFE DATA USING TWO METHODS: QUALITY ADJUSTED SURVIVAL EFFECT SIZES AND JOINT MODELLING. (11th November 2019)

7. Symptom clusters in newly diagnosed glioma patients: which symptom clusters are independently associated with functioning and global health status?. Issue 11 (5th June 2019)

8. The added value of health-related quality of life as a prognostic indicator of overall survival and progression-free survival in glioma patients: a meta-analysis based on individual patient data from randomised controlled trials. (July 2019)